In silico modification of Zn2+binding group of suberoylanilide hydroxamic acid (SAHA) by organoselenium compounds asHomo sapiensclass II HDAC inhibitor of cervical cancer | Zendy

AI Assistant Blog Pricing

In silico modification of Zn2+binding group of suberoylanilide hydroxamic acid (SAHA) by organoselenium compounds asHomo sapiensclass II HDAC inhibitor of cervical cancer

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.